Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

You only have one brain and so it’s important to buy the best motorbike helmet you can afford. That doesn’t always mean spending £1000+ on a race-ready carbon lid, though, and there are ...

Unlike a single-piece full-face helmet, a flip-front has a separate chin-bar that lifts up, exposing the face while the helmet is still on. Not only does this allow people to see your face for ID ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...